Publication | Closed Access

Real-world adverse events associated with CAR T-cell therapy among adults age ≥ 65 years

Real-world Adverse EventsAdverse EventClinical TrialsAdults AgeImmunotherapyMedicineCellular TherapiesEpidemiologyRegulatory T Cell BiologyCar T-cell Therapy